Day: January 5, 2021

ASi Ekspress Grupp kontserni kuuluv 100%-line tütarettevõte SIA D Screens ostis SIA-lt DIMAXI viie välise digiekraaniga võrgustiku Riias. Tehingu tulemusena kasvas D Screensi võrgustik neljateistkümnele digiekraanile.Pooled on leppinud kokku mitte avaldada tehingu hinda ja muid tehingu tingimusi.Kontsern jätkab aktiivselt välimeediavõrgustiku investeeringutega nii Lätis kui ka Eestis.ASile Ekspress Grupp kuulub ka välimeediaettevõte Linna Ekraanid, mis haldab 35 väliekraaniga võrgustikku üle Eesti. Ostu järel kuulub Ekspress Grupile Lätis 14 ja Eestis 35 digiekraani. Kokku 49 ekraaniga on Ekspress Grupp piirkonna suuruselt teine välimeediaekraanide omanik ning ainus ettevõte, mis suudab pakkuda oma klientidele digitaalset välimeediareklaami korraga nii Eestis kui ka Lätis.Signe KukinKontserni finantsjuhtAS Ekspress Grupp+372 669 8381signe.kukin@egrupp.eeSIA...

Heijmans, together with housing corporation Stichting Woonbedrijf SWS.Hhvl and architect VenhoevenCS, has won the tender for the construction and management of 735 student homes on the grounds of Eindhoven University of Technology (TU/e). The first partial delivery of the project is scheduled for the start of the 2023-2024 academic year. Heijmans’ part of the project has a value of approximately EUR 60 million.Two residential tower blocks and a social heartThe plan consists of two residential tower blocks with 653 student homes. The space between the tower blocks will be used to house the (low-rise) social heart of the project, and will include 82 student homes, a shop, a creative space and spaces to be filled in consultation with students. Vestide, the Woonbedrijf housing corporation’s student accommodation division, will be responsible...

Heijmans heeft samen met stichting Woonbedrijf SWS.Hhvl en architect VenhoevenCS de aanbesteding gewonnen voor de bouw en het beheer van 735 studentenwoningen op het terrein van de Eindhoven University of Technology. De eerste deeloplevering van de bouw is gepland voor aanvang van collegejaar 2023-2024. Het project heeft voor Heijmans een waarde van circa € 60 miljoen.Twee woontorens en sociaal hartHet plan bestaat uit twee woontorens (653 studentenwoningen) met daartussen een laagbouw (82 studentenwoningen). Met name de laagbouw vormt het sociale hart met onder meer een kringloopwinkel, een creatieve ruimte en in overleg met studenten nader in te vullen ruimtes. De verhuur en het beheer van woningen is voor een periode van 50 jaar in handen van Vestide, de merknaam waaronder de studentenhuisvester van Woonbedrijf bekend is. Het project...

MONT-SAINT-GUIBERT, Belgium, Jan. 05, 2021 (GLOBE NEWSWIRE) — Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company plans to participate at the following conferences in January 2021:H.C. Wainwright BioConnect ConferenceDate: January 11 – 14, 2021Time: On-demand, January 11 at 6:00 a.m. (EST) / 12:00 p.m. CETWebcast: A live and archived webcast of the presentation will be available in the Events section of the Celyad Oncology websiteKeystone eSymposiaDate: Monday, January 25, 2021Time: 10:00 a.m. ET / 4:00 p.m. CETA live and archived webcast of available presentations will be on the Events section of the Celyad Oncology websiteAbout Celyad OncologyCelyad...

IPH6101/SAR443579 is an NKp46-based NK cell engager (NKCE) that uses Innate’s proprietary multispecific antibody formatSelection of IPH6101/SAR443579 triggers a €7M milestone payment to InnateMARSEILLE, France, Jan. 05, 2021 (GLOBE NEWSWIRE) —Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that Sanofi has made the decision to progress IPH6101/SAR443579 into investigational new drug (IND)-enabling studies. IPH6101/SAR443579 is a NKp46-based NK cell engager (NKCE) using Innate’s proprietary multispecific antibody format (Gauthier et al. Cell 2019).In the first research program of the collaboration, IPH6101/SAR443579 has shown anti-tumor activity in pre-clinical models, including encouraging pharmacokinetic (PK), pharmacodynamic (PD) and safety data in preliminary...

Marseille, Jan. 05, 2021 (GLOBE NEWSWIRE) —IPH6101/SAR443579 is an NKp46-based NK cell engager (NKCE) that uses Innate’s proprietary multispecific antibody formatSelection of IPH6101/SAR443579 triggers a €7M milestone payment to InnateInnate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that Sanofi has made the decision to progress IPH6101/SAR443579 into investigational new drug (IND)-enabling studies. IPH6101/SAR443579 is a NKp46-based NK cell engager (NKCE) using Innate’s proprietary multispecific antibody format (Gauthier et al. Cell 2019).In the first research program of the collaboration, IPH6101/SAR443579 has shown anti-tumor activity in pre-clinical models, including encouraging pharmacokinetic (PK), pharmacodynamic (PD) and safety data in preliminary non-human...

Marseille, 05 janv. 2021 (GLOBE NEWSWIRE) —IPH6101/SAR443579 est un anticorps multispécifique engageant les cellules NK (NKCE) via leur récepteur activateur NKp46 et utilisant le format d’anticorps multispécifique propriétaire d’Innate  La sélection d’IPH6101/SAR443579 déclenche un paiement d’étape de 7 millions d’euros à InnateInnate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») a annoncé aujourd’hui que Sanofi a pris la décision de faire progresser IPH6101/SAR443579 vers les études précliniques réglementaires visant l’étude d’un nouveau médicament expérimental. IPH6101/SAR443579 est un anticorps multispécifique engageant les cellules NK (NKCE) via leur récepteur activateur NKp46 et utilisant le format d’anticorps multispécifique propriétaire d’Innate (Gauthier et al. Cell...

Polarcus Limited (“Polarcus” or the “Company”) (OSE: PLCS) announces the Company’s fourth quarter and full year 2020 vessel utilization as follows:Polarcus Nadia and Polarcus Amani are excluded from vessel utilization subsequent to stacking in April 2015 and September 2020 respectively.The Company will release its fourth quarter 2020 report on 24 February 2021 at approximately 07:00hrs CET (10:00hrs UAE). A webcast and conference call will be hosted by Polarcus commencing at 09:00hrs CET (12:00hrs UAE). ContactsHans-Peter Burlid, CFO+971 50 559 8175hp.burlid@polarcus.com About PolarcusThis information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Tiragolumab is the first anti-TIGIT therapy to be granted Breakthrough Therapy Designation (BTD) and marks the 37th BTD for Roche’s portfolio of medicinesBTD is based on the randomised phase II CITYSCAPE study that showed encouraging efficacy and safety with tiragolumab plus Tecentriq (atezolizumab) in people with PD-L1-positive metastatic non-small cell lung cancerBroad tiragolumab development programme is ongoing across various settings in different tumour types, including lung, oesophageal and cervical cancersBasel, 5 January 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that tiragolumab, a novel cancer immunotherapy designed to bind to TIGIT, has been granted Breakthrough Therapy Designation (BTD) by the US Food and Drug Administration (FDA), in combination with Tecentriq® (atezolizumab) for the first-line treatment...

Killeen, TX/2021: There are a number of benefits that members of a credit union get to enjoy in addition to the services offered. If you are keen on becoming a credit union member in Killeen, TX, you should consider visiting the Greater Central Texas Federal Credit Union, a member owned cooperative that strives to provide its members with the best financial services and products at affordable rates. About The Credit Union The credit union was formed in 1957 by a group of 9 teachers who contributed some money as a means of providing affordable financial assistance to one another in times of need. It has since then soared into a reputed credit union in Killeen, TX that is known for its superior financial and lending services. The credit union is a member of prestigious organizations such as NCUA, Equal Housing Opportunity and BBB. It is...